|
⚲
|
| Keyboard |
| Ashleigh Palmer | |
|---|---|
| Firm | |
| Address | Third Pole, Inc 309 Waverley Oaks Road, Suite 404 Waltham, MA 02452 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Third Pole Inc | 021-335121 | Director | 55.2 M | ||
| Provention Bio Inc | 021-286073 | Executive Officer | 28.5 M of 30.0 M |
||
| Third Pole Inc | 021-253728 | Director | 13.8 M of 14.0 M |
||
| Tolera Therapeutics Inc | 021-224862 | Executive Officer | 0.2 M | ||
| Unigene Laboratories Inc | 021-195335 | Executive Officer | 0.8 M of 0.8 M |
||
| Unigene Laboratories Inc | 021-185215 | Executive Officer | 4.0 M of 7.5 M |
||
| Tarsa Therapeutics Inc | 021-175388 | Director | 13.8 M of 28.0 M |
||
| Tarsa Therapeutics Inc | 021-148747 | Director | 15.5 M of 24.5 M |
||
| Critical Biologics Corp | 021-99265 | Executive Officer | 0.5 M of 1.6 M |
||